-transparent.png){kind=logo}
The refinement of the techniques of programmed stimulation and intracardiac recording has provided an understanding of the mechanism of ventricular tachycardia which can be applied clinically to the development of therapeutic regimens. The efficacy of drug therapy can be assessed by sequential studies evaluating the ability of drugs to prevent the initiation of the arrhythmia. The efficacy of pacemaker therapy can be evaluated by the effects of stimulation during the tachycardia. The recent development of endocardial mapping provides the surgeon with a tool to guide therapeutic surgical ablation. We believe that such an electrophysiologic approach to recurrent ventricular tachycardia can lead to the rapid development of successful therapy under controlled conditions.
M E Josephson, and
J A Kastor, and
L N Horowitz
October 1981,
Chest,
M E Josephson, and
J A Kastor, and
L N Horowitz
June 1983,
American heart journal,
M E Josephson, and
J A Kastor, and
L N Horowitz
March 1988,
Circulation,
M E Josephson, and
J A Kastor, and
L N Horowitz
October 1965,
New York state journal of medicine,
M E Josephson, and
J A Kastor, and
L N Horowitz
March 2017,
Cardiac electrophysiology clinics,
M E Josephson, and
J A Kastor, and
L N Horowitz
September 1980,
Hospital practice,
M E Josephson, and
J A Kastor, and
L N Horowitz
January 1979,
The Medical clinics of North America,
M E Josephson, and
J A Kastor, and
L N Horowitz
March 1983,
American heart journal,
M E Josephson, and
J A Kastor, and
L N Horowitz
February 1981,
Journal of the Medical Association of Georgia,
M E Josephson, and
J A Kastor, and
L N Horowitz
April 1989,
Minerva cardioangiologica,
